Results 1 to 10 of about 87,371,428 (168)

Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States [PDF]

Drug and Alcohol Dependence Reports, 2023
Research objective: Medication opioid use disorder (MOUD) treatment is the first-line approach to the treatment of opioid use disorder (OUD). This analysis seeks to identify “critical access” MOUD facilities that ensure geographic access for MOUD ...
Harold A. Pollack, Francis Lee, Susan Paykin, Javier Andres Rojas Aguilera   +3 more
doaj   +4 more sources

Factors contributing to the expansion of medication for opioid use disorder (MOUD) within the New Hampshire Department of Corrections (NHDOC) [PDF]

Health & Justice
Introduction Expanding access to medication for opioid use disorder (MOUD) to people involved in the carceral system is a priority for the New Hampshire Department of Corrections (NHDOC), where more than 40% of residents have an opioid use disorder (OUD).
Nancy Clayman, Pracha Eamranond, Helen Hanks, Michael Mitcheff, Lisa RappaMannion, Diane York, Paula Mattis, Heidi Guinen, Alex Carp, Laura Olson, Kathleen Bell, Lydia Shahi, Elizabeth Saunders, Joshua Lee, Lisa Marsch   +14 more
doaj   +3 more sources

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other ...
Megan K. Reed, Kelsey R. Smith, Francesca Ciocco, Richard W. Hass, Avery Lin Cox, Erin L. Kelly, Lara C. Weinstein   +6 more
doaj   +3 more sources

The fentanyl made me feel like I needed more methadone”: changes in the role and use of medication for opioid use disorder (MOUD) due to fentanyl [PDF]

Harm Reduction Journal
Background Fentanyl and fentanyl analogues have disrupted the illicit drug supply through contamination of other substances (i.e., methamphetamine and cocaine) and replacement of heroin in illicit markets.
Maria Bolshakova, Kelsey A. Simpson, Siddhi S. Ganesh, Jesse L. Goldshear, Cheyenne J. Page, Ricky N. Bluthenthal   +5 more
doaj   +2 more sources

Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model [PDF]

Implementation Research and Practice, 2023
Background Access to providers and programs that provide medications for opioid use disorder (MOUD) remains a systemic barrier for patients with opioid use disorder (OUD), particularly if they live in rural areas.
Renee M. Cloutier, Evan S. Cole, Brianna L. McDonough, Daniel A. Lomauro, John P. Miller, Abigail L. Talbert, Todd M. Bear, Nora C. Bridges, Abigail L. Foulds, Rachel Taber, Adam J. Gordon, Gerald T. Cochran, Julie Kmiec, Julie M. Donohue, David Kelley, Ellen DiDomenico, Dale Adair, Janice L. Pringle   +17 more
doaj   +2 more sources

Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes [PDF]

Mental Health Clinician, 2023
Introduction: At a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder ...
Kim Ehrhard, PharmD, BCPP, Michelle Colvard, PharmD, BCPP, Jennifer Brabson, PharmD, BCPP   +2 more
doaj   +1 more source

Telemedication for Opioid Use Disorder: A New Approach for Treatment

Telemedicine Reports, 2023
Objective: This study aimed to determine the effect that the transition to incorporating remote care had on patients in medication for opioid use disorder (MOUD) treatment and to identify benefits and gaps in services due to this transition.
Rebecca A. Georgiadis, Paige Sable, Daniel Rosen   +2 more
doaj   +1 more source

Development and use of a checklist for the implementation of medication for opioid use disorder in jails

Implementation Research and Practice, 2022
Background: In light of short lengths of stay and proximity to communities of release, jails are well-positioned to intervene in opioid use disorder (OUD). However, a number of barriers have resulted in a slow and limited implementation.
Ariel Ludwig, Laura B. Monico, Thomas Blue, Michael S. Gordon, Robert P. Schwartz, Shannon Gwin Mitchell   +5 more
doaj   +1 more source

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Introduction: Psychosocial support is recommended in conjunction with medication for opioid use disorder (MOUD), although optimal “dose,” modality, and timing of participation is not established.
Kathryn Hefner, Tse-Hwei Choo, Dikla Shmueli-Blumberg, Martina Pavlicova, Jacquie King, Marc Fishman, Matisyahu Shulman, Aimee Campbell, Miranda Greiner, Jennifer Scodes, Sarah Meyers-Ohki, Patricia Novo, Edward Nunes, John Rotrosen   +13 more
doaj   +1 more source

Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial

Addiction Science & Clinical Practice, 2021
Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities.
Yih-Ing Hser, Allison J. Ober, Alex R. Dopp, Chunqing Lin, Katie P. Osterhage, Sarah E. Clingan, Larissa J. Mooney, Megan E. Curtis, Lisa A. Marsch, Bethany McLeman, Emily Hichborn, Laurie S. Lester, Laura-Mae Baldwin, Yanping Liu, Petra Jacobs, Andrew J. Saxon   +15 more
doaj   +1 more source